Literature DB >> 32522999

America's opioid crisis: the need for an integrated public health approach.

Carlos Blanco1, Tisha R A Wiley2, Jacqueline J Lloyd2, Marsha F Lopez2, Nora D Volkow2.   

Abstract

Continued increases in overdose deaths and recent declines in life expectancy call for need to adopt comprehensive public health approaches to the United States opioid crisis and to establish an infrastructure to avert future crises. Successfully addressing the challenges posed by the crisis requires a translational, integrated approach that combines the contribution of neuroscience, pharmacology, epidemiology, treatment services and prevention. It also is critical to integrate interventions across settings, including healthcare, justice, education and social service systems. This review highlights four interconnected themes: (1) social determinants of health and disease; (2) person-centered approaches for prevention and treatment; (3) bridging the gap between implementation science and practice; and (4) using data to build learning systems of care, relevant to public health approaches to address the opioid crisis. We discuss how across these four themes taking into account the influence of developmental factors on brain function and sensitivity to environmental stimuli including drugs, addressing the complex interactions between biological and social factors, and promoting an ongoing dialogue across disciplines and settings will help accelerate public health advances that are evidenced based and sustainable to address the current opioid crisis and avert future ones.

Entities:  

Year:  2020        PMID: 32522999      PMCID: PMC7286889          DOI: 10.1038/s41398-020-0847-1

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  51 in total

Review 1.  Management of opioid use disorder in the USA: present status and future directions.

Authors:  Carlos Blanco; Nora D Volkow
Journal:  Lancet       Date:  2019-03-14       Impact factor: 79.321

2.  Correlates of Prescription Opioid Use, Misuse, Use Disorders, and Motivations for Misuse Among US Adults.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Christopher M Jones
Journal:  J Clin Psychiatry       Date:  2018-08-14       Impact factor: 4.384

3.  Toward a Comprehensive Developmental Model of Prescription Opioid Use Disorder.

Authors:  Carlos Blanco; Melanie M Wall; Shang-Min Liu; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2019-12-03       Impact factor: 4.384

4.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

5.  Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Silvia S Martins; Aaron Sarvet; Julian Santaella-Tenorio; Tulshi Saha; Bridget F Grant; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

6.  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.

Authors:  Anne Case; Angus Deaton
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

7.  Pain as a Predictor of Opioid Use Disorder in a Nationally Representative Sample.

Authors:  Carlos Blanco; Melanie M Wall; Mayumi Okuda; Shuai Wang; Miren Iza; Mark Olfson
Journal:  Am J Psychiatry       Date:  2016-07-22       Impact factor: 18.112

8.  Longitudinal effects of universal preventive intervention on prescription drug misuse: three randomized controlled trials with late adolescents and young adults.

Authors:  Richard Spoth; Linda Trudeau; Chungyeol Shin; Ekaterina Ralston; Cleve Redmond; Mark Greenberg; Mark Feinberg
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

9.  Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

Authors:  Traci C Green; Jennifer Clarke; Lauren Brinkley-Rubinstein; Brandon D L Marshall; Nicole Alexander-Scott; Rebecca Boss; Josiah D Rich
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 25.911

10.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

View more
  15 in total

1.  Need for and Receipt of Substance Use Disorder Treatment Among Adults, by Gender, in the United States.

Authors:  Caitlin E Martin; Anna Beth Parlier-Ahmad; Lori Beck; Anna Scialli; Mishka Terplan
Journal:  Public Health Rep       Date:  2021-09-21       Impact factor: 3.117

2.  Perception of Resource Allocations to Address the Opioid Epidemic.

Authors:  Justin C Strickland; Grant Victor; Bradley Ray
Journal:  J Addict Med       Date:  2022 Sep-Oct 01       Impact factor: 4.647

3.  A Comparison of Sex-Specific Reproductive and Sexual Health Needs between Addiction Medicine and Primary Care Treatment Settings.

Authors:  Caitlin E Martin; Anna Beth Parlier-Ahmad; Lori Beck; Vashali Jain; Mishka Terplan
Journal:  Subst Use Misuse       Date:  2022-05-23       Impact factor: 2.362

4.  Interpersonal Trauma Among Women and Men Receiving Buprenorphine in Outpatient Treatment for Opioid Use Disorder.

Authors:  Caitlin E Martin; Anna Beth Parlier-Ahmad; Lori Beck; Nicholas D Thomson
Journal:  Violence Against Women       Date:  2021-12-13

5.  Trends in heroin use and injection drug use among high school students in five urban school districts in the US (2005-2017).

Authors:  Renee M Johnson; Denali Boon; Xinzi Wang; Lauren B Beach; Sherri-Chanelle Brighthaupt; Kristin E Schneider; Gregory Phillips
Journal:  J Ethn Subst Abuse       Date:  2021-10-27       Impact factor: 1.331

6.  Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine?

Authors:  R Kathryn McHugh; Blake T Hilton; Alexandra M Chase; Margaret L Griffin; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2021-09-20       Impact factor: 4.492

7.  Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Dennis P Watson
Journal:  J Subst Abuse Treat       Date:  2020-12-11

8.  Research on substance use disorders during the COVID-19 pandemic.

Authors:  Nora D Volkow; Carlos Blanco
Journal:  J Subst Abuse Treat       Date:  2021-04-08

9.  Strengthening Communities: A Qualitative Assessment of Opportunities for the Prevention of Adverse Childhood Experiences in the Wake of the Opioid Crisis.

Authors:  Jennifer L Matjasko; Gary Chovnick; Joivita Bradford; Sarah Treves-Kagan; Kristen Usher; Elizabeth Vaughn; Erin Ingoldsby
Journal:  J Child Fam Stud       Date:  2022-01-03

10.  Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.

Authors:  Xiayun Wan; Yuko Fujita; Lijia Chang; Yan Wei; Li Ma; Gerile Wuyun; Yaoyu Pu; Bruce D Hammock; Kenji Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.